Jeffrey Trigilio - Oct 15, 2021 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
Chief Financial Officer
Signature
/s/ Jeffrey Trigilio
Stock symbol
CGEM
Transactions as of
Oct 15, 2021
Transactions value $
-$165,600
Form type
4
Date filed
10/18/2021, 04:15 PM
Previous filing
Sep 9, 2021
Next filing
Feb 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Options Exercise $34.4K +8K +355.56% $4.30 10.3K Oct 15, 2021 Direct
transaction CGEM Common Stock Sale -$200K -8K -78.05% $25.00 2.25K Oct 15, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGEM Stock Option (Right to Buy) Options Exercise $0 -8K -3.36% $0.00 230K Oct 15, 2021 Common Stock 8K $4.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 30, 2021.
F2 25% of the shares vested on September 8, 2021, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.